David Gandara
@drgandara
Medical Oncologist & clinical-translational researcher in lung cancer. Co-Director-Center for Experimental Therapeutics, UC Davis Comprehensive Cancer Center
ID: 806198593925353472
06-12-2016 18:08:18
5,5K Tweet
7,7K Takipçi
538 Takip Edilen
At Cal Cancer Consortium conference, Jonathan Riess shows impact of baseline positive vs negative plasma ctDNA for EGFR in the FLAURA2 trial. Addition of chemo to Osi mainly benefitting those with positive ctDNA. Food for thought! UC Davis Comprehensive Cancer Cent City of Hope USC Norris Comprehensive Cancer Center